Sign up to save your podcasts
Or
Share GeoVax Labs to Present Clinical Data on COVID-19 Vaccine and Oncology Therapy at Industry Events
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
GeoVax Labs to Present Clinical Data on COVID-19 Vaccine and Oncology Therapy at Industry Events
GeoVax Labs, Inc. will be presenting clinical data at two upcoming industry events in April. They will discuss the Phase 2b study results comparing their COVID-19 vaccine candidate to an approved vaccine at the World Vaccine Congress, and present on Gedeptin therapy for solid tumors at the American Association of Cancer Research. GeoVax is a biotech company focused on developing vaccines for infectious diseases and therapies for solid tumor cancers.
View all episodes
GeoVax Labs, Inc. will be presenting clinical data at two upcoming industry events in April. They will discuss the Phase 2b study results comparing their COVID-19 vaccine candidate to an approved vaccine at the World Vaccine Congress, and present on Gedeptin therapy for solid tumors at the American Association of Cancer Research. GeoVax is a biotech company focused on developing vaccines for infectious diseases and therapies for solid tumor cancers.